NCT00035633已完成3 期
A Phase III Study of Entecavir vs Lamivudine in Adults With Chronic Hepatitis B Infection and Positive for Hepatitis B E Antigen
Bristol-Myers Squibb38 个研究点 分布在 1 个国家开始时间: 2001年12月最近更新:
适应症
相关药物
试验速览
- 阶段
- 3 期
- 状态
- 已完成
- 发起方
- 试验地点
- 38
研究概览
简要总结
The purpose of this clinical research study is to assess the safety effectiveness of entecavir, as compared to lamivudine, in the treatment of adults with chronic hepatitis B infection who are hepatitis B e antigen positive.
研究设计
- 研究类型
- Interventional
- 主要目的
- Treatment
入排标准
- 年龄范围
- 16 Years 至 —（Child, Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- 未提供
排除标准
- 未提供
研究者
研究点 (38)
Loading locations...
相似试验
已完成
3 期
A Phase III Study of Entecavir vs Lamivudine in Adults With Chronic Hepatitis B Infection and Negative for Hepatitis B e AntigenChronic Hepatitis BNCT00035789Bristol-Myers Squibb
已完成
3 期
A Phase III Study of Entecavir vs Lamivudine in Chronic Hepatitis B Subjects With Incomplete Response to LamivudineChronic Hepatitis BNCT00036608Bristol-Myers Squibb
已完成
2 期
Study of Adding Entecavir to Current Lamivudine Therapy in HIV and HBV Co-Infected PatientsHepatitis BNCT00051038Bristol-Myers Squibb
终止
4 期
Comparison Between Lamivudine and Entecavir Treatment in Spontaneous Severe Acute ExacerbationChronic Hepatitis BNCT01627223Taichung Veterans General Hospital17
进行中（未招募）
2 期
Study to Evaluate the Safety and Efficacy of Lenacapavir (GS-6207) in Combination With an Optimized Background Regimen (OBR) in Heavily Treatment Experienced Participants Living With HIV-1 Infection With Multidrug ResistanceHIV-1-infectionNCT04150068Gilead Sciences72